null Skip to main content

✨ Buy more, save 5% Ends

Developments in T Cell Based Cancer Immunotherapies

Developments in T Cell Based Cancer Immunotherapies - Hardback

$179.29
(No reviews yet) Write a Review
Physical book delivery

Shipping calculated at checkout.

Estimated delivery
Adding to cart… The item has been added
Product Details
Author:
Paolo a. Ascierto
Publisher:
Humana
Publication Date:
Dec 04, 2015
Number of pages:
305 pages
Binding:
Hardback or Cased Book
ISBN-10:
3319211668
ISBN-13:
9783319211664

Overview

This volume illustrates the salient aspects of cancer biology relevant to the successful implementation of immunotherapy. Topics include enhancement of antigen-specific immune responses by anti-cancer vaccines, modulation of the function of T cells within the tumor microenvironment, and the effects of genetic, epigenetic, developmental, and environmental determinants on T cell function. Other topics covered include the ex vivo expansion of T or other immune cells and their genetic modification or reprogramming to increase their ability to survive and expand when adoptively transferred back to the patients. Specific attention is devoted to the genetic manipulation of T cells through the introduction of re-directed T cell receptors, chimeric antibody receptors, and other genetic manipulation aimed at improving their effectiveness as anti-cancer agents. Furthermore, the revolutionary role of checkpoint inhibitors and their potential in combination with other immunotherapeutic approaches or with standard chemo and radiation therapy are extensively discussed.


  • | Author: Paolo a. Ascierto
  • | Publisher: Humana
  • | Publication Date: Dec 04, 2015
  • | Number of Pages: 305 pages
  • | Binding: Hardback or Cased Book
  • | ISBN-10: 3319211668
  • | ISBN-13: 9783319211664

Reviews

0 Reviews

Write a Review

No reviews yet.

Share your experience and help another reader choose their next book.

Discover your next great book

Get new releases, reader favourites, and special offers delivered to your inbox.